Kerbel, Robert S.

Angiogenesis as a therapeutic target

Ferrara, N., & Kerbel, R. S. (2005) · Nature

Angiogenesis and VEGF in CancerLymphatic System and Diseases

Cited by 2,653

β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis

Dennis, J. W., Laferté, S., Waghorne, C., Breitman, M. L., & Kerbel, R. S. (1987) · Science

Glycosylation and Glycoproteins ResearchCarbohydrate Chemistry and Synthesis

Cited by 940

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

Ebos, J. M. L., & Kerbel, R. S. (2011) · Nature Reviews Clinical Oncology

Angiogenesis and VEGF in CancerCancer Cells and Metastasis

Cited by 685

Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy

Ebos, J. M. L., Lee, C. R., & Kerbel, R. S. (2009) · Clinical Cancer Research

Angiogenesis and VEGF in CancerCancer Cells and Metastasis

Cited by 291

Vessel Co-option Is Common in Human Lung Metastases and Mediates Resistance to Anti-angiogenic Therapy in Preclinical Lung Metastasis Models

Bridgeman, V. L., Vermeulen, P. B., Foo, S., Bilecz, A., Daley, F., Kostaras, E., Nathan, M. R., Wan, E., Frentzas, S., Schweiger, T., et al. (2017) · The Journal of Pathology

Angiogenesis and VEGF in CancerCancer Cells and Metastasis

Cited by 214

Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers

Wu, F. T. H., Man, S., Xu, P., Chow, A., Paez-Ribes, M., Lee, C. R., Pirie-Shepherd, S. R., Emmenegger, U., & Kerbel, R. S. (2016) · Cancer Research

Angiogenesis and VEGF in CancerLymphatic System and Diseases

Cited by 58

Raising the bar for cancer therapy models

Francia, G., & Kerbel, R. S. (2010) · Nature Biotechnology

Cancer Cells and MetastasisAnimal testing and alternatives

Cited by 54

Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease

Wu, F. T. H., Xu, P., Chow, A., Man, S., Krüger, J., Khan, K. A., Paez-Ribes, M., Pham, E., & Kerbel, R. S. (2019) · British Journal of Cancer

Cancer Immunotherapy and BiomarkersRenal cell carcinoma treatment

Cited by 47

Dose-Dependent Increases in Circulating TGF-α and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent

Mutsaers, A. J., Francia, G., Man, S., Lee, C. R., Ebos, J. M. L., Wu, Y., Witte, L., Berry, S., Moore, M., & Kerbel, R. S. (2009) · Clinical Cancer Research

HER2/EGFR in Cancer ResearchColorectal Cancer Treatments and Studies

Cited by 34